National Health Investors (NYSE:NHI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, Zacks.com reports. The firm currently has a $75.00 price target on the real estate investment trust’s stock. Zacks Investment Research‘s price objective indicates a potential upside of 12.07% from the stock’s previous close.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
Several other research firms have also recently issued reports on NHI. Berenberg Bank cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, December 2nd. ValuEngine cut National Health Investors from a “hold” rating to a “sell” rating in a research note on Thursday, October 1st. KeyCorp raised National Health Investors from an “underweight” rating to a “sector weight” rating in a research note on Monday, December 14th. Finally, BMO Capital Markets cut National Health Investors from a “market perform” rating to an “underperform” rating and set a $68.00 target price on the stock. in a research note on Thursday, January 7th. Three research analysts have rated the stock with a sell rating and seven have issued a hold rating to the stock. National Health Investors has an average rating of “Hold” and a consensus price target of $65.63.
NHI opened at $66.92 on Tuesday. The company has a market cap of $2.99 billion, a P/E ratio of 15.71 and a beta of 0.85. The business’s 50-day moving average price is $67.72 and its 200-day moving average price is $62.94. The company has a current ratio of 13.13, a quick ratio of 13.13 and a debt-to-equity ratio of 1.02. National Health Investors has a 12 month low of $31.37 and a 12 month high of $91.12.
National Health Investors (NYSE:NHI) last released its quarterly earnings data on Monday, November 9th. The real estate investment trust reported $0.95 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.43 by ($0.48). The company had revenue of $84.30 million during the quarter, compared to analysts’ expectations of $82.87 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.42 EPS. Equities research analysts forecast that National Health Investors will post 5.63 earnings per share for the current fiscal year.
In other news, Director Robert G. Adams acquired 2,000 shares of the business’s stock in a transaction on Monday, December 14th. The shares were acquired at an average cost of $67.75 per share, with a total value of $135,500.00. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Robert G. Adams purchased 1,000 shares of the company’s stock in a transaction dated Tuesday, November 17th. The stock was bought at an average cost of $66.45 per share, for a total transaction of $66,450.00. The disclosure for this purchase can be found here. Insiders own 5.74% of the company’s stock.
Institutional investors and hedge funds have recently modified their holdings of the company. Private Advisor Group LLC purchased a new position in National Health Investors in the 2nd quarter worth approximately $31,000. Marshall Wace North America L.P. purchased a new position in National Health Investors in the 1st quarter worth approximately $31,000. Van ECK Associates Corp raised its holdings in National Health Investors by 23.5% in the 3rd quarter. Van ECK Associates Corp now owns 1,298 shares of the real estate investment trust’s stock worth $78,000 after acquiring an additional 247 shares during the last quarter. Avantax Advisory Services Inc. purchased a new position in National Health Investors in the 3rd quarter worth approximately $202,000. Finally, Campbell & CO Investment Adviser LLC purchased a new position in National Health Investors in the 3rd quarter worth approximately $209,000. 62.41% of the stock is currently owned by hedge funds and other institutional investors.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Recommended Story: Why is cost of goods sold important?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.